On 6/27/24, Wave Life Sciences Ltd (NASDAQ: WVE) stock enjoyed a major increase of 14.1%, closing at $4.99. Moreover, trading volume in this advance was exceptionally high at 232% of normal. The stock has declined -12.6% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
WVE’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
Wave Life Sciences has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Wave Life Sciences has a very low Appreciation Score of 1 but a neutral Power Rating of 51, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment